Tag: percutaneous coronary intervention

1. Device thrombosis occurred at a higher rate in patients undergoing percutaneous coronary intervention (PCI) utilizing a bioabsorbable scaffold compared to a metallic stent, both of which were covered in everolimus. 2. Failure of vessel revascularization and cardiac death occurs at similar rates for PCI procedures utilizing bioresorbable scaffolds and...
1. Rate of death, stroke, and MI at three years were equivalent in patients with left main coronary disease treated with either everolimus-eluting stent or coronary-artery bypass grafting (CABG). 2. Ischemia-driven revascularization at three years was equivalent in the two groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Randomized trials have suggested...
1. In this systematic review and meta-analysis, radial percutaneous access during invasive management of acute coronary syndrome was associated with decreased mortality, major adverse coronary events, and major bleeding when compared to femoral access. 2. However, radial artery access was associated with higher cross-over to femoral access. Evidence Rating Level: 1...
1. From a cohort study of Danish patients presenting with acute coronary syndrome, early invasive revascularization interventions were associated with reduced cardiac mortality when compared to conservative invasive strategies. 2. Early intervention was also associated with decreased all-cause mortality and re-hospitalization within 60 days compared to conservative intervention. Evidence Rating Level:...
1. There was no difference in long term mortality amongst patients who underwent either fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) or intravascular ultrasonography (IVUS)-guided PCI compared to angiography-guided PCI amongst patients undergoing elective or urgent PCI in the London, UK area.  2. Fewer total stents were implanted in...
Image: PD 1. For patients with multivessel disease, coronary artery bypass grafting (CABG) conferred a hazard ratio (HR) for death of 0.92, as compared to percutaneous coronary intervention (PCI).   2. The survival benefit of CABG over PCI was especially pronounced among patients with history of peripheral arterial disease, tobacco use, diabetes, and...
Image: PD 1. Major adverse cardiac event rates at 30 days and 12 months after percutaneous coronary intervention are similar at hospitals with or without on-site cardiac surgery. 2. Procedural success rates are similar with or without on-site cardiac surgery while outcomes vary based on the hospitals. Published today, this randomized study found...